Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Results available

Radiation Therapy Combined With Paclitaxel and Carboplatin in Treating Patients With Stage III Non-Small Cell Lung Cancer

ClinicalTrials.gov ID: NCT00023673

Public ClinicalTrials.gov record NCT00023673. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 6:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I/II Dose Intensification Study Using Three Dimensional Conformal Radiation Therapy And Concurrent Chemotherapy For Patients With Inoperable, Non-Small Cell Lung Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving them with specialized radiation therapy may kill more tumor cells. PURPOSE: This phase I/II trial is studying the effectiveness of radiation therapy combined with paclitaxel and carboplatin in treating patients who have stage III non-small cell lung cancer.

Study identification

NCT ID
NCT00023673
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Enrollment
63 participants

Conditions and interventions

Conditions

Interventions

Drug · Radiation

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2001 (Type not available)
Primary completion
Jan 2009 (Actual)
Completion
Nov 2013 (Actual)
Last update posted
Dec 22, 2017

2001 – 2013

United States locations

U.S. sites
40
U.S. states
19
U.S. cities
33
Facility City State ZIP Site status
Mobile Infirmary Medical Center Mobile Alabama 36652-2144 —
Arizona Oncology Services Foundation Phoenix Arizona 85013 —
Providence Saint Joseph Medical Center - Burbank Burbank California 91505 —
Providence Holy Cross Cancer Center Mission Hills California 91346-9600 —
University of California Davis Cancer Center Sacramento California 95817 —
Bay Medical Panama City Florida 32401 —
Northeast Georgia Medical Center Gainesville Georgia 30501 —
Saint Anthony's Hospital at Saint Anthony's Health Center Alton Illinois 62002 —
Alexian Brothers Radiation Oncology Elk Grove Village Illinois 60007 —
Good Samaritan Regional Health Center Mount Vernon Illinois 62864 —
Oncology Center at Saint Margaret Mercy Healthcare Center Hammond Indiana 46320 —
Cancer Center at Ball Memorial Hospital Muncie Indiana 47303-3499 —
Regional Cancer Center at Singing River Hospital Pascagoula Mississippi 39581 —
Southeast Missouri Regional Cancer Center at Southeast Missouri Hospital Cape Girardeau Missouri 63701 —
Cancer Institute of Cape Girardeau, LLC Cape Girardeau Missouri 63703 —
Saint Francis Medical Center Cape Girardeau Missouri 63703 —
CCOP - Cancer Research for the Ozarks Springfield Missouri 65802 —
Hulston Cancer Center at Cox Medical Center South Springfield Missouri 65807 —
CCOP - St. Louis-Cape Girardeau St Louis Missouri 63141 —
David C. Pratt Cancer Center at St. John's Mercy St Louis Missouri 63141 —
Ocean Medical Center at Meridian Health Brick New Jersey 08724 —
J. Phillip Citta Regional Cancer Center at Community Medical Center Toms River New Jersey 08755 —
Franklin & Edith Scarpa Regional Cancer Center at South Jersey Healthcare Vineland New Jersey 08360 —
CCOP - Hematology-Oncology Associates of Central New York East Syracuse New York 13057 —
High Point Regional Hospital High Point North Carolina 27261 —
Summa Center for Cancer Care at Akron City Hospital Akron Ohio 44309-2090 —
Cleveland Clinic Cancer Center at Fairview Hospital Cleveland Ohio 44111 —
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195 —
Cancer Treatment Center Wooster Ohio 44691 —
Three Rivers Community Hospital Grants Pass Oregon 97527 —
Dubs Cancer Center at Rogue Valley Medical Center Medford Oregon 97504 —
Providence Cancer Center at PMCC Medford Oregon 97504 —
Albert Einstein Cancer Center Philadelphia Pennsylvania 19141 —
Rapid City Regional Hospital Rapid City South Dakota 57701 —
University of Texas Medical Branch Galveston Texas 77555-0361 —
Joe Arrington Cancer Research and Treatment Center Lubbock Texas 79410-1894 —
Schiffler Cancer Center at Wheeling Hospital Wheeling West Virginia 26003 —
Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center La Crosse Wisconsin 54601 —
Medical College of Wisconsin Cancer Center Milwaukee Wisconsin 53226 —
Veterans Affairs Medical Center - Milwaukee Milwaukee Wisconsin 53295 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00023673, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 22, 2017 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00023673 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →